(Q53393723)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18564459%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

title

Taking the next steps in the diagnosis of Alzheimer's disease: the use of biomarkers (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18564459%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

0 references

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18564459%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1

Steven T DeKosky

1 reference

13 May 2018

http://europepmc.org/abstract/MED/18564459

publication date

1 March 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18564459%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18564459%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18564459%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

3 Suppl 3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18564459%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

7-10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18564459%20AND%20SRC:MED&resulttype=core&format=json

Rates of global and regional cerebral atrophy in AD and frontotemporal dementia.

9 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017193

7 January 2021

Neuropathological stageing of Alzheimer-related changes

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017193

7 January 2021

Change in rates of cerebral atrophy over time in early-onset Alzheimer's disease: longitudinal MRI study

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017193

7 January 2021

Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017193

7 January 2021

Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017193

7 January 2021

Regional brain atrophy rate predicts future cognitive decline: 6-year longitudinal MR imaging study of normal aging

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017193

7 January 2021

https://api.crossref.org/works/10.1017%2FS1092852900017193

1 reference

7 January 2021

Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-D-glucose/positron-emission tomography (FDG/PET).

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017193

7 January 2021

Blood transcriptional signatures of multiple sclerosis: unique gene expression of disease activity

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017193

7 January 2021

Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017193

7 January 2021

Human blood genomics: distinct profiles for gender, age and neurofibromatosis type 1.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017193

7 January 2021

Looking Backward to Move Forward: Early Detection of Neurodegenerative Disorders

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017193

7 January 2021

Tracking atrophy progression in familial Alzheimer's disease: a serial MRI study

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017193

7 January 2021

Plasma Abeta(1-40) and Abeta(1-42) and the risk of dementia: a prospective case-cohort study.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017193

7 January 2021

Phases of A beta-deposition in the human brain and its relevance for the development of AD.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017193

7 January 2021

Imaging cerebral atrophy: normal ageing to Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017193

7 January 2021

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017193

7 January 2021

Pathology and pathways of Alzheimer's disease with an update on new developments in treatment.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017193

7 January 2021

Imaging beta-amyloid burden in aging and dementia.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017193

7 January 2021

Mild cognitive impairment: clinical characterization and outcome

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017193

7 January 2021

Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017193

7 January 2021

Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017193

7 January 2021

Longitudinal Magnetic Resonance Imaging Studies of Older Adults: A Shrinking Brain

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017193

7 January 2021

Changes in premorbid brain volume predict Alzheimer's disease pathology

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017193

7 January 2021

Early marker for Alzheimer's disease: the atrophic hippocampus.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017193

7 January 2021

Presymptomatic hippocampal atrophy in Alzheimer's disease. A longitudinal MRI study

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017193

7 January 2021

Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017193

7 January 2021

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017193

7 January 2021

Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017193

7 January 2021

Hippocampal formation glucose metabolism and volume losses in MCI and AD.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017193

7 January 2021

Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017193

7 January 2021

Amyloid beta protein 1-40 and 1-42 levels in matched cerebrospinal fluid and plasma from patients with Alzheimer disease

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017193

7 January 2021

Transcriptional profiling of peripheral blood cells in clinical pharmacogenomic studies

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017193

7 January 2021

Using peripheral blood mononuclear cells to determine a gene expression profile of acute ischemic stroke: a pilot investigation.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017193

7 January 2021

Transcriptional profiling of Alzheimer blood mononuclear cells by microarray

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017193

7 January 2021

Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017193

7 January 2021

CSF markers for incipient Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017193

7 January 2021

Decreased beta-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017193

7 January 2021

CSF tau protein phosphorylated at threonine 231 correlates with cognitive decline in MCI subjects

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017193

7 January 2021

PET of brain amyloid and tau in mild cognitive impairment.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017193

7 January 2021

Molecular imaging with Pittsburgh Compound B confirmed at autopsy: a case report

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017193

7 January 2021

Amyloid, hypometabolism, and cognition in Alzheimer disease: an [11C]PIB and [18F]FDG PET study

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017193

7 January 2021

11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017193

7 January 2021

Plasma A[beta]40 and A[beta]42 and Alzheimer's disease: relation to age, mortality, and risk

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900017193

7 January 2021

10.1017/S1092852900017193

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18564459%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference